Insight Molecular Diagnostics, Inc. (IMDX)
3.76
+0.24
(+6.82%)
USD |
NASDAQ |
Apr 24, 16:00
3.76
0.00 (0.00%)
After-Hours: 20:00
Insight Molecular Diagnostics Total Assets (Quarterly) : 25.76M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| FONAR Corp. | 217.22M |
| Interpace Biosciences, Inc. | 33.84M |
| Thermo Fisher Scientific, Inc. | 113.28B |
| XWELL, Inc. | 11.22M |
| Hypha Labs, Inc. | 0.3916M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 57.22M |
| Shareholders Equity (Quarterly) | -31.46M |
| Debt to Equity Ratio | -0.1111 |
| Current Ratio | 1.268 |
| Net Debt Paydown Yield | 0.05% |